These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


203 related items for PubMed ID: 24783249

  • 1. Combining TNFSF15 and ASCA IgA can be used as a predictor for the stenosis/perforating phenotype of Crohn's disease.
    Tung CC, Wong JM, Lee WC, Liu HH, Chang CH, Chang MC, Chang YT, Shieh MJ, Wang CY, Wei SC.
    J Gastroenterol Hepatol; 2014 Apr; 29(4):723-9. PubMed ID: 24783249
    [Abstract] [Full Text] [Related]

  • 2. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.
    Walker LJ, Aldhous MC, Drummond HE, Smith BR, Nimmo ER, Arnott ID, Satsangi J.
    Clin Exp Immunol; 2004 Mar; 135(3):490-6. PubMed ID: 15008984
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases.
    Saibeni S, Folli C, de Franchis R, Borsi G, Vecchi M.
    Dig Liver Dis; 2003 Dec; 35(12):862-8. PubMed ID: 14703881
    [Abstract] [Full Text] [Related]

  • 5. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A, Zurakowski D, Young W, Leichtner A, Bousvaros A.
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [Abstract] [Full Text] [Related]

  • 6. Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a Swiss Cohort.
    Schoepfer AM, Schaffer T, Mueller S, Flogerzi B, Vassella E, Seibold-Schmid B, Seibold F.
    Inflamm Bowel Dis; 2009 Sep; 15(9):1358-67. PubMed ID: 19253375
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases.
    Bartůnková J, Kolárová I, Sedivá A, Hölzelová E.
    Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458
    [Abstract] [Full Text] [Related]

  • 11. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
    Paul S, Boschetti G, Rinaudo-Gaujous M, Moreau A, Del Tedesco E, Bonneau J, Presles E, Mounsef F, Clavel L, Genin C, Flourié B, Phelip JM, Nancey S, Roblin X.
    J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.
    Nisihara RM, de Carvalho WB, Utiyama SR, Amarante H, Baptista ML.
    Dig Dis Sci; 2010 Aug; 55(8):2309-15. PubMed ID: 19826949
    [Abstract] [Full Text] [Related]

  • 13. Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's disease.
    Klebl FH, Bataille F, Hofstädter F, Herfarth H, Schölmerich J, Rogler G.
    Int J Colorectal Dis; 2004 Jul; 19(4):319-24. PubMed ID: 14745572
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serological markers facilitate the diagnosis of Crohn's disease.
    Gao X, Zhang Y.
    Postgrad Med; 2021 Apr; 133(3):286-290. PubMed ID: 33406965
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease.
    Sandborn WJ, Loftus EV, Colombel JF, Fleming KA, Seibold F, Homburger HA, Sendid B, Chapman RW, Tremaine WJ, Kaul DK, Wallace J, Harmsen WS, Zinsmeister AR, Targan SR.
    Inflamm Bowel Dis; 2001 Aug; 7(3):192-201. PubMed ID: 11515844
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods.
    Linskens RK, Mallant-Hent RC, Groothuismink ZM, Bakker-Jonges LE, van de Merwe JP, Hooijkaas H, von Blomberg BM, Meuwissen SG.
    Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):1013-8. PubMed ID: 12352222
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.